Erlotinib in Advanced Non-small Cell Lung Cancer: Efficacy and Safety Findings of the Global Phase IV Tarceva Lung Cancer Survival Treatment Study

Details 詳細情報について

• CRID

  1363388844544421248

• DOI

  10.1097/jto.0b013e3181f1c7b0

• ISSN

  15560864

• Web Site

  https://api.elsevier.com/content/article/PII:S1556086415318098?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S1556086415318098?httpAccept=text/plain

• Data Source

  • Crossref